Oral manifestations in patients affected by COVID-19 and their levels of treatment in environments with dental support: an integrative literature review
DOI:
https://doi.org/10.33448/rsd-v11i9.31737Keywords:
COVID-19; Oral Manifestations; Dental care.Abstract
Introduction: The new coronavirus disease or COVID-19 causes an infection that can affect the respiratory system and trigger disorders in vital organs of the human body, in addition to having a high rate of transmissibility and causing several comorbidities. Among its main symptoms, the following stand out: fever, cough, headache, diarrhea, fatigue and myalgia. The diagnosis of this pathology may be associated with oral manifestations such as edema. Objectives: To compile the possible oral manifestations in patients with COVID-19. Methodology: This is an integrative literature review. To collect information, searches were made in PubMed, Scientific Electronic Library Online and Virtual Health Library databases by consulting the descriptors: “COVID-19”, “Oral Manifestations” and “Dental Care”. Full articles in English, Portuguese and/or Spanish published between 2015 and 2022 were selected. Results: 29 studies were selected whose analysis allowed to identify that the appearance of oral manifestations in patients with a positive diagnosis for COVID-19 can be promising. To detect the progression of the new coronavirus, there is an association of its signs and symptoms such as dysgeusia, hypogeusia, anosmia and hyposalivation, concomitantly associated with the appearance of oral pathologies such as aphthous lesions, ulcers and periodontitis. Conclusions: Although the literature does not have definitive conclusions about the direct relationship between COVID-19 and oral manifestations, it has been evidenced in almost its entirety in the analyzed studies. Therefore, it is important to emphasize the role of the dental surgeon in the early detection and treatment of pathological manifestations that may be related to SARS-CoV-2, thus reducing the morbidity and mortality of cases.
References
Ansari, R., Gheitani, M., Heidari, F., & Heidari, F. (2020). Oral cavity lesions as a manifestation of the novel virus (COVID‐19): a letter‐to‐editor. Oral Diseases. https://doi.org/10.1111/odi.13465.
Baeder, F. M., Albuquerque, A. C. L., Corraza, P. F. L., Weigert, K. L., Puicelli, E., Pasetti, L. A., Serrão, M. C. P. N., Cardoso, A. M. R., Brito Filho, M. T. B., Teodósio, G. C., Bomfim, M. A. C., Sobrinho, A. C. P., Forghieri, A. A., & Silva, D. F. (2021). Oral lesions in patients infected with SARS-CoV-2: a case series. Research, Society and Development, 10(4), e45410414349. https://doi.org/10.33448/rsd-v10i4.14349.
Brandão, T. B., Gueiros, L. A., Melo, T. S., Prado-Ribeiro, A. C., Nesrallah, A. C. F. A., Prado, G. V. B., Santos-Silva, A. R., & Migliorati, C. A. (2020). Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://doi.org/10.1016/j.oooo.2020.07.014.
Biadsee, A., Biadsee, A., Kassem, F., Dagan, O., Masarwa, S., & Ormianer, Z. (2020). Olfactory and Oral Manifestations of COVID-19: Sex-Related Symptoms—A Potential Pathway to Early Diagnosis. Otolaryngology–Head and Neck Surgery, 163(4), 722–728. https://doi.org/10.1177/0194599820934380.
Corchuelo, J., & Ulloa, F. C. (2020). Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report. International Journal of Infectious Diseases, 100, 154–157. https://doi.org/10.1016/j.ijid.2020.08.071.
Dilsiz, A., Parlak, E., & Gül, S. S. (2022). Oral and ocular manifestations in a patient with coronavirus disease-2019: Clinical presentation and management. Revista Da Sociedade Brasileira de Medicina Tropical, 55. https://doi.org/10.1590/0037-8682-0699-2021.
Freeman, T. L., & Swartz, T. H. (2020). Targeting the NLRP3 Inflammasome in Severe COVID-19. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01518.
Iranmanesh, B., Amiri, R., Zartab, H., & Aflatoonian, M. (2020). Oral manifestations of COVID ‐19 disease: A review article. Dermatologic Therapy. https://doi.org/10.1111/dth.14578.
Ling, M. R., Chapple, I. L., & Matthews, J. B. (2015). Peripheral blood neutrophil cytokine hyper-reactivity in chronic periodontitis. Innate Immunity, 21(7), 714–725. https://doi.org/10.1177/1753425915589387.
Maciel, P. P., Martelli Júnior, H., Martelli, D. R. B., Machado, R. A., Andrade, P. V. de, Perez, D. E. da C., & Bonan, P. R. F. (2020). COVID-19 Pandemic: Oral Repercussions and its Possible Impact on Oral Health. Pesquisa Brasileira Em Odontopediatria E Clínica Integrada, 20 (suppl 1). https://doi.org/10.1590/pboci.2020.135.
Medeiros, F. B., Buhatem Medeiros, A. C. A., Timerman, L., Alves, L. A. C., & Santos, P. S. S. (2020). Doenças Virais e seu Impacto na Odontologia. Revista Da Sociedade de Cardiologia Do Estado de São Paulo, 30(4), 545–548. https://doi.org/10.29381/0103-8559/20203004545-8.
Mendes, K. D. S., Silveira, R. C. C. P., & Galvão, C. M. (2019). Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto Contexto Enferm, 28, 1 - 13. https://doi.org/10.1590/1980-265X-TCE-2017-0204
Moher, D., Liberati, A., Tetzlaff, J., & Altman D. G. (2009). “The PRISMA Group". Preferred Reporting Items for Systematic Reviews and Meta - Analyses: The PRISMA Statement. Plos Medicine, 6(7) e1000097. https://doi.org/10.1371/journal.pmed.1000097
Moraes, M. F., Natalino, Y. R, Holanda, A. F., Souza Sobrinho, H. F., Sarmento, L.C., Gomes, A. P. M., & Sanglard, L. F. (2021). Oral and cutaneous manifestations of covid-19 in pediatric patients. RGO - Revista Gaúcha de Odontologia, 69. https://doi.org/10.1590/1981-86372021000520200136.
Parra-Sanabria, E. A., Bermúdez-Bermúdez, M., Peña-Vega, C. P., & Rueda-Jiménez, A. (2020). Manifestaciones orales y maxilofaciales asociadas a la COVID-19. Revisión de la literatura. Acta Odontológica Colombiana, 10 ((Supl.COVID–19)). https://doi.org/10.15446/aoc.v10n3.89447.
Pedrosa, M. S., Sipert, C. R., & Nogueira, F. N. (2020). Salivary Glands, Saliva and Oral Findings in COVID-19 Infection. Pesquisa Brasileira Em Odontopediatria E Clínica Integrada, 20(suppl 1). https://doi.org/10.1590/pboci.2020.112.
Priya, H., Singh, G., Mishra, D., Kumar, H., Monga, N., & Kumari, K. (2021). Oral manifestations and dental practice recommendations during COVID-19 pandemic. Journal of Family Medicine and Primary Care, 10(1), 102. https://doi.org/10.4103/jfmpc.jfmpc_1605_20.
Rodríguez, M. D., Romera, A. J., & Villarroel, M. (2020). Oral manifestations associated with COVID‐19. Oral Diseases. https://doi.org/10.1111/odi.13555.
Santos, J. A., Normando, A. G. C., Silva, R. L. C., Paula, R. M., Cembranel, A. C, Santos-Silva, A. R., & Guerra, E. N. S. (2020). Oral Manifestations in Patients with COVID-19: A Living Systematic Review. Journal of Dental Research, 100(2), 141–154. https://doi.org/10.1177/0022034520957289.
Santos, J. A., Normando, A. G. C., Silva, R. L. C., Paula, R. M., Cembranel, A. C, Santos-Silva, A. R., & Guerra, E. N. S. (2020). Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? International Journal of Infectious Diseases, 97, 326–328. https://doi.org/10.1016/j.ijid.2020.06.012.
Santos, S. V., Freitas, I. P., Senna, S. F. M., Carvalho, L. P., & Faria, S. A. (2021, September 13). Manifestações orais do Covid-19: uma breve revisão da literatura. Revista Odontológica de Araçatuba. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1291673.
Schwab, G., Palmieri, M., Zerbinati, R. M., Sarmento, D. J. S., Reis, T., Ortega, K. L., Kano, I. T., Caixeta, R. A. V., Hasséus, B., Sapkota, D., Junges, R., Giannecchini, S., Costa, A. L. F., Jales, S. M. C. P., Lindoso, J. A. L., Gallo, C. B., & Braz-Silva, P. H. (2022). Lack of direct association between oral mucosal lesions and SARS-CoV- 2 in a cohort of patients hospitalised with COVID-19. Journal of Oral Microbiology, 14(1). https://doi.org/10.1080/20002297.2022.2047491.
Siu, K., Yuen, K., Castano‐Rodriguez, C., Ye, Z., Yeung, M., Fung, S., Yuan, S., Chan, C., Yuen, K., Enjuanes, L., & Jin, D. (2019). Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3‐dependent ubiquitination of ASC. The FASEB Journal, 33(8), 8865–8877. https://doi.org/10.1096/fj.201802418r.
Souza, M. T. de., Silva, M. D. da., & Carvalho, R. de. (2010). Integrative review: what is it? How to do it? Einstein (São Paulo), 8(1), 102–106. https://doi.org/10.1590/s1679-45082010rw1134.
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 20(6), 1–12. https://doi.org/10.1038/s41577-020-0311-8.
Tomo, S., Miyahara, G. I., & Simonato, L. E. (2020). Oral mucositis in a SARS‐CoV‐2‐infected patient: Secondary or truly associated condition? Oral Diseases. https://doi.org/10.1111/odi.13570.
Tuon, F. F., Gavrilko, O., Almeida, S., Sumi, E. R., Alberto, T., Rocha, J. L., & Rosa, E. A. (2017). Prospective, randomised, controlled study evaluating early modification of oral microbiota following admission to the intensive care unit and oral hygiene with chlorhexidine. Journal of Global Antimicrobial Resistance, 8, 159–163. https://doi.org/10.1016/j.jgar.2016.12.007.
Vinayachandran, D., & Balasubramanian, S. (2020). Is gustatory impairment the first report of an oral manifestation in COVID‐19? Oral Diseases. https://doi.org/10.1111/odi.13371.
Zarch, R. E., & Hosseinzadeh, P. (2021). COVID ‐19 from the perspective of dentists: A case report and brief review of more than 170 cases. Dermatologic Therapy, 34(1). https://doi.org/10.1111/dth.14717.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 William José Lopes de Freitas Júnior ; Kezia Maria Dias Silva ; Emanuel Pedro Felix Vieira ; Maria Luiza Greco de Oliveira Lira; Vanessa Maria de Andrade Nogueira ; William José Lopes de Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
